#ACR23 Year in Review. CAR-T cell showed promising results in #SLE based on case series but extrapolation to other RMD may be challenging. -Myositis recurred after 7days, needing MMF -No improvement in lung fibrosis #SSc Longer-term data & trial data are needed @RheumNow https://t.co/4Zmjvr51Ab